Article Sidebar
Views pdf: 77
APPLICATION OF SANGER SEQUENCING TO DETECT CYP21A2 MUTATIONS CAUSING CONGENITAL ADRENAL HYPERPLASIA DISEASE
Main Article Content
Abstract
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder usually caused by a deficiency of the enzyme 21-hydroxylase. The deficiency of the enzyme 21-hydroxylase occurs due to mutations in the CYP21A2 gene, of which about 60% of CAH patients carry point mutations in the CYP21A2 gene. The study was carried out with the aim of screening point mutations on CYP21A2 gene using Sanger sequencing technique. 30 patients were diagnosed with congenital adrenal hyperplasia with 21- hydroxylase deficiency was collected; DNA extracted from blood samples was carried out; PCR and Sanger sequencing was performed to identify mutations. Results: 11 patients carry genetic mutations that cause CAH were found, including 10 patients with the salt-wasting phenotype and 1 patient with the simple virilization phenotype. The most common mutation is I2G (16.7%), followed by p.R356W (5%) and p.R426C (5%), the remaining mutations range from 1.7% - 3%.
Article Details
Keywords
Congenital adrenal hyperplasia, CYP21A2, point mutation, Sanger sequencing
References
2. Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 Sep 27;103(11):4043–88.
3. Choi JH, Jin HY, Lee BH, Ko JM, Lee JJ, Kim GH, et al. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency. Exp Clin Endocrinol Diabetes. 2012 Jan;120(1):23–7.
4. Usui T, Nishisho K, Kaji M, Ikuno N, Yorifuji T, Yasuda T, et al. Three novel mutations in Japanese patients with 21-hydroxylase deficiency. Horm Res. 2004;61(3):126–32.
5. Balraj P, Lim PG, Sidek H, Wu LL, Khoo ASB. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia. J Endocrinol Invest. 2013 Jun;36(6):366–74.
6. Grischuk Y, Rubtsov P, Riepe FG, Grötzinger J, Beljelarskaia S, Prassolov V, et al. Four Novel Missense Mutations in the CYP21A2 Gene Detected in Russian Patients Suffering from the Classical Form of Congenital Adrenal Hyperplasia: Identification, Functional Characterization, and Structural Analysis. The Journal of Clinical Endocrinology & Metabolism. 2006 Dec 1;91(12):4976–80.
7. Koyama S, Toyoura T, Saisho S, Shimozawa K, Yata J. Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab. 2002 Jun;87(6):2668–73.
8. Chi DV, Tran TH, Nguyen DH, Luong LH, Le PT, Ta MH, et al. Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia. Mol Genet Genomic Med. 2019 Feb 27;7(5):e623.
9. Xia Y, Shi P, Gao S, Liu N, Zhang H, Kong X. Genetic analysis and novel variation identification in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The Journal of Steroid Biochemistry and Molecular Biology. 2022 Sep 1;222:106156.
10. New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2611–6.